Effective treatment of a patient with stage IV ovarian cancer: A case report

被引:10
|
作者
Huang, Zhen [1 ]
Yan, Hua [2 ]
Chavan, Devendra [1 ]
Yuan, Zeng [1 ]
Yang, Xingsheng [1 ]
Zhang, Youzhong [1 ]
Song, Kun [1 ]
Kong, Beihua [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Spleen & Stomach Dis, Jinan 250012, Shandong, Peoples R China
关键词
interval cytoreductive surgery; neoadjuvant chemotherapy; post-surgery chemotherapy; ovarian neoplasms; treatment; PEGYLATED LIPOSOMAL DOXORUBICIN; DEBULKING SURGERY; CHEMOTHERAPY; TRABECTEDIN;
D O I
10.3892/ol.2017.7285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present case report describes a patient with stage IV ovarian cancer who survived for 9 years without achieving a complete remission since the first relapse. The patient's long-term survival may be ascribed to the slow growth of the cancer cells, limited metastasis and favorable responses to the treatments received. The patient manifested initially with malignant pleural effusion and was not able to tolerate surgical treatment. However, the disease was well-controlled using various treatments, including neoadjuvant chemotherapy, interval cytoreductive surgery and post-operative long-term chemotherapy. Management of ovarian cancer is most effective when tailored to the individual needs of the patient, maximizing its efficacy and prolonging the patient's survival rate. The present case may offer useful insight into the clinical management of stage IV ovarian cancer
引用
收藏
页码:588 / 591
页数:4
相关论文
共 50 条
  • [21] Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer
    Chern, Jing-Yi
    Curtin, John P.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) : 1 - 10
  • [22] Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer
    Eo, Wankyu
    Kim, Hong-Bae
    Lee, Yong Joo
    Suh, Dong Soo
    Kim, Ki Hyung
    Kim, Heungyeol
    JOURNAL OF CANCER, 2016, 7 (13): : 1772 - 1779
  • [23] Organ sparing to cure stage IV rectal cancer: A case report and review of literature
    Meillat, Helene
    Garnier, Jonathan
    Palen, Anais
    Ewald, Jacques
    de Chaisemartin, Cecile
    Tyran, Marguerite
    Mitry, Emmanuel
    Lelong, Bernard
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 15 (11): : 2619 - 2626
  • [24] Treatment of patients with stage IV gastric cancer
    Ikeguchi M.
    Kader A.
    Takaya S.
    Fukumoto Y.
    Osaki T.
    Saito H.
    Tatebe S.
    Wakatsuki T.
    Journal of Gastrointestinal Cancer, 2013, 44 (2) : 199 - 202
  • [25] Treatment strategies for patients with stage IV rectal cancer: A report from the Swedish Rectal Cancer Registry
    Khani, M. Hosseinali
    Pahlman, L.
    Smedh, K.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (11) : 1616 - 1623
  • [26] Effect of different treatment modalities on the prognosis of stage IV epithelial ovarian cancer: analysis of the SEER database
    Zhang, Shuyuan
    Zhang, Hongyong
    Jia, Naer
    Suo, Suo
    Guo, Jianfeng
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [27] Stage IV uterine prolapse and pregnancy: A case report
    Lecointre, L.
    Gaudineau, A.
    Langer, B.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2014, 43 (07): : 530 - 532
  • [28] Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer
    Timmermans, Maite
    Sonke, G. S.
    Van de Vijver, K. K.
    Ottevanger, P. B.
    Nijman, H. W.
    van der Aa, M. A.
    Kruitwagen, R. F. P. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (02) : 392 - 397
  • [29] Epithelial ovarian cancer: A case report
    Gao, Jianyuan
    Fang, Haiying
    Wang, Xiaoming
    Wu, Liping
    Zhang, Ronghuai
    Han, Yajun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (05) : 1535 - 1538
  • [30] Multiple stage IV colorectal cancers in a patient who received multidisciplinary treatment, including chemotherapy and Japanese Kampo medicine: A case report
    Aomatsu, Naoki
    Maeda, Kiyoshi
    Uchima, Yasutake
    Matsutani, Shinji
    Tsujio, Gen
    Miyamoto, Hironari
    Okada, Takuma
    Kurihara, Shigeaki
    Nishii, Takafumi
    Tachimori, Akiko
    Ikeda, Katsumi
    Takeuchi, Kazuhiro
    NEUROPEPTIDES, 2021, 88